Transitional Cell Carcinoma Unknown Status Phase 3 Trials for Doxorubicin (DB00997)

Also known as: Carcinoma, Transitional Cell / Carcinoma transitional cell / Transitional cell carcinoma (morphologic abnormality)

IndicationStatusPhase
DBCOND0031000 (Transitional Cell Carcinoma)Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03296306Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial CarcinomaTreatment